
What we're reading ... January 29, 2010
Each week the staff of CURE shares some of what they've been reading the past week with our readers. Please let us know what you think and what you've been reading, too!Radiation Therapy
This series in The New York Times addresses mistakes made with new radiation technology. It's hard to read, but patients need to be aware of such issues and advocate for their own care at facilities that understand the latest technology. I do need to point out that radiation has proven to be a great treatment for many cancer patients. You can read the first of the series at
Kathy LaTour
Editor-at-Large & cancer survivorOvarian Cancer
Controversy has plagued a consensus statement issued in 2007 that identified a handful of symptoms that were meant to help diagnose ovarian cancer earlier. Now, research published online January 28 in the Journal of the National Cancer Institute found that these symptoms result in a diagnosis only 1 percent of the time. An editorial, which accompanied the study, offers perspective on the research findings and the utility of the specific symptoms:
Melissa Weber
Managing Editor, CURE Prostate CancerIf you haven't had a chance to read Dana Jennings' columns in The New York Times on life with prostate cancer, go back and read every one of them. Jennings' columns are eloquent, powerful, and thoughtful, and he writes from the heart about the impact cancer has on the patient, family, and friends. Here is his latest:
Lena Huang
Fitness & Nutrition Editor Cancer Research
Although it's rather technical, but along the lines of my research interest, an interesting journal article in The Journal of Clinical Investigation explores tumor heterogeneity, or differences between the cells within a tumor. We used to think of cancer cells as all identical to each other, or clones of each other, but now we are seeing them more as an ecosystem in evolution--with evolution that may have implications in metastasis and drug resistance.
The article abstract is at
Debu Tripathy, MD
Editor-in-ChiefChildhood Cancer
While I think cancer at any age is horrible, it seems especially sad for childhood patients. While I'm sure the project talked about in "
Bunmi Ishola
Editorial AssistantRisk Factors
Alexandra Hurd
Marketing and PR specialist





